ARTIVION, INC. (AORT) Gross Margin
- Gross margin · 12 months: Value 64.37%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 64.37% | Gross profit / revenue. Period ending 2026-06-30. $303.50M ÷ $471.47M × 100 ≈ 64.37% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 303.50M USD | Gross Profit |
| Revenue | 471.47M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 167.97M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $303.50M | $471.47M | $167.97M | 64.37% |
| 2026-03-31 | $296.10M | $458.69M | $162.59M | 64.55% |
| 2025-12-31 | $284.23M | $441.33M | $157.10M | 64.40% |
| 2025-09-30 | $272.59M | $422.65M | $150.06M | 64.50% |
| 2025-06-30 | $259.20M | $405.04M | $145.84M | 63.99% |
| 2025-03-31 | $249.41M | $390.08M | $140.67M | 63.94% |
| 2024-12-31 | $248.78M | $388.54M | $139.76M | 64.03% |
| 2024-09-30 | $248.37M | $384.90M | $136.53M | 64.53% |
| 2024-06-30 | $243.63M | $376.97M | $133.34M | 64.63% |
| 2024-03-31 | $238.40M | $368.21M | $129.81M | 64.75% |
| 2023-12-31 | $229.18M | $354.00M | $124.83M | 64.74% |
| 2023-09-30 | $218.97M | $339.73M | $120.76M | 64.45% |
| 2023-06-30 | $211.44M | $328.72M | $117.27M | 64.32% |
| 2023-03-31 | $205.53M | $319.81M | $114.27M | 64.27% |
| 2022-12-31 | $202.52M | $313.79M | $111.27M | 64.54% |
| 2022-09-30 | $203.01M | $313.79M | $110.78M | 64.70% |
| 2022-06-30 | $202.05M | $309.15M | $107.10M | 65.36% |
| 2022-03-31 | $200.40M | $304.96M | $104.57M | 65.71% |
| 2021-12-31 | $197.51M | $298.84M | $101.32M | 66.09% |
| 2021-09-30 | $190.73M | $287.34M | $96.61M | 66.38% |
| 2021-06-30 | $186.07M | $275.60M | $94.19M | 67.51% |
| 2021-03-31 | $171.45M | $257.88M | $86.43M | 66.48% |
| 2020-12-31 | $167.78M | $253.23M | $85.44M | 66.26% |
| 2020-09-30 | $169.75M | $255.03M | $85.28M | 66.56% |
| 2020-06-30 | $171.84M | $257.78M | $85.94M | 66.66% |
| 2020-03-31 | $182.91M | $275.15M | $92.23M | 66.48% |
| 2019-12-31 | $183.01M | $276.22M | $93.21M | 66.26% |
| 2019-09-30 | $181.65M | $274.32M | $92.67M | 66.22% |
| 2019-06-30 | $179.14M | $271.04M | $91.90M | 66.09% |
| 2019-03-31 | $178.03M | $268.40M | $90.37M | 66.33% |
| 2018-12-31 | $172.98M | $262.84M | $89.86M | 65.81% |
| 2018-09-30 | $164.16M | $247.87M | $83.71M | 66.23% |
| 2018-06-30 | $151.30M | $227.27M | $75.97M | 66.57% |
| 2018-03-31 | $138.36M | $206.59M | $68.23M | 66.97% |
| 2017-12-31 | $128.64M | $189.70M | $61.06M | 67.81% |
| 2017-09-30 | $123.47M | $181.91M | $58.43M | 67.88% |
| 2017-06-30 | $123.39M | $183.16M | $59.76M | 67.37% |
| 2017-03-31 | $120.79M | $182.42M | $61.63M | 66.21% |
| 2016-12-31 | $118.90M | $180.38M | $61.48M | 65.92% |
| 2016-09-30 | $114.22M | $175.19M | (m) | 65.20% |
| 2016-06-30 | $107.42M | $166.64M | $59.22M | 64.46% |
| 2016-03-31 | $98.67M | $155.08M | $56.41M | 63.63% |
| 2015-12-31 | $90.72M | $145.90M | $55.18M | 62.18% |
| 2015-09-30 | $86.84M | $143.21M | $56.37M | 60.64% |
| 2015-06-30 | $87.66M | $143.58M | $55.92M | 61.05% |
| 2015-03-31 | $88.48M | $142.74M | $54.26M | 61.99% |
| 2014-12-31 | $91.29M | $144.64M | $53.35M | 63.12% |
| 2014-09-30 | $90.94M | $142.95M | $52.01M | 63.62% |
| 2014-06-30 | $90.49M | $142.13M | $51.64M | 63.67% |
| 2014-03-31 | $89.58M | $140.96M | $51.38M | 63.55% |
| 2013-12-31 | $90.39M | $140.76M | $50.38M | 64.21% |
| 2013-09-30 | $89.15M | $138.11M | $48.96M | 64.55% |
| 2013-06-30 | $87.11M | $135.28M | $48.17M | 64.39% |
| 2013-03-31 | $87.00M | $134.95M | $47.95M | 64.47% |
| 2012-12-31 | $85.02M | $131.72M | $46.70M | 64.55% |
| 2012-09-30 | $83.35M | $129.31M | $45.97M | 64.45% |
| 2012-06-30 | $80.95M | $125.54M | $44.59M | 64.48% |
| 2012-03-31 | $78.63M | $121.73M | $43.10M | 64.59% |
| 2011-12-31 | $75.84M | $119.63M | $43.78M | 63.40% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $68.37M | $116.64M | $48.28M | 58.61% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $69.77M | $111.69M | $41.92M | 62.47% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |